June 09, 2020

The Coronavirus Pandemic is Reigniting a Fierce Debate Over Compounded Drugs-STAT

In hopes of alleviating potential drug shortages and other issues wrought by the coronavirus pandemic, the Food and Drug Administration drastically rolled back its oversight of compounding pharmacies — a swift and sweeping relaxing of the rules that were put in place after a fungal meningitis outbreak traced to one such center killed more than 60 and sickened over 700. STAT, 06/09/2020